EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Transforming clinical trials: the emerging roles of large language models

Jong-Lyul Ghim iD, Sangzin Ahn iD

Translational and Clinical Pharmacology · 2023 · 31 (3) · 131

DOI: 10.12793/tcp.2023.31.e16 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational and Clinical Pharmacology, 2023. Verfasst von Jong-Lyul Ghim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan 47392, Korea. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical trials are essential for medical research, but they often face challenges in matching patients to trials and planning. Large language models (LLMs) offer a promising solution, signaling a transformative shift in the field of clinical trials. This review explores the multifaceted applications of LLMs within clinical trials, focusing on five main areas expected to be implemented in the near future: enhancing patient-trial matching, streamlining clinical trial planning, analyzing free text narratives for coding and classification, assisting in technical writing tasks, and providing cognizant consent via LLM-powered chatbots. While the application of LLMs is promising, it poses challenges such as accuracy validation and legal concerns. The convergence of LLMs with clinical trials has the potential to revolutionize the efficiency of clinical trials, paving the way for innovative methodologies and enhancing patient engagement. However, this development requires careful consideration and investment to overcome potential hurdles.

Schlagwörter

Stichwörter der Autor:innen

Artificial IntelligenceClinical TrialInformed ConsentMedical WritingNatural Language Processing

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan 47392, Korea.
  • Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan 47392, Korea.
  • Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Busan 47392, Korea.

ORCID-Profile: Jong-Lyul Ghim, Sangzin Ahn

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Ghim, J. L., & Ahn, S. (2023). Transforming clinical trials: the emerging roles of large language models. Translational and Clinical Pharmacology, 31(3), 131. https://doi.org/10.12793/tcp.2023.31.e16

Vancouver

Ghim JL, Ahn S. Transforming clinical trials: the emerging roles of large language models. Translational and Clinical Pharmacology. 2023;31(3):131. doi:10.12793/tcp.2023.31.e16

BibTeX
@article{Ghim2023,
  author = {Ghim, Jong-Lyul and Ahn, Sangzin},
  title = {Transforming clinical trials: the emerging roles of large language models},
  journal = {Translational and Clinical Pharmacology},
  year = {2023},
  volume = {31},
  number = {3},
  pages = {131},
  doi = {10.12793/tcp.2023.31.e16}
}
Kostenlos starten →